Back to News
Market Impact: 0.2

SpaceX vs. Rocket Lab: Which One Will Dominate the Next Decade?

NVDAINTCAAPLNFLX
IPOs & SPACsCompany FundamentalsCorporate EarningsTechnology & InnovationPrivate Markets & VentureAnalyst InsightsInvestor Sentiment & Positioning
SpaceX vs. Rocket Lab: Which One Will Dominate the Next Decade?

SpaceX is described as potentially preparing for the largest IPO in history at a $2 trillion valuation, versus Rocket Lab’s $37 billion market cap and $602 million in 2025 revenue. The article emphasizes SpaceX’s much larger scale, with roughly $18.5 billion in revenue and $8.0 billion in EBITDA, while Rocket Lab grew revenue 38% year over year but remained EBITDA-negative at negative $185.5 million. The piece is largely a comparative stock commentary, concluding Rocket Lab offers more upside despite SpaceX’s dominance.

Analysis

The key market implication is not that one company is “better,” but that the IPO would likely re-rate the entire commercial launch / satellite ecosystem by forcing public-market investors to benchmark every space name against a quasi-infinite-capital competitor. That is structurally negative for smaller, pre-profitability challengers because the leader can use valuation currency and vertical integration to compress margins across launch, connectivity, and adjacent data services while still funding capex through public equity. The second-order winner is likely the picks-and-shovels layer: avionics, propulsion components, ground systems, and specialty materials suppliers that benefit from industry growth without taking balance-sheet risk. The biggest issue for the smaller pure-play is timing mismatch. If a mega-IPO happens in the next 6-12 months, the competitive narrative will likely outrun operating proof points, and investors may punish any slip in backlog conversion, launch cadence, or gross margin expansion. Conversely, if the IPO slips or is structured with limited float, the hype premium may remain concentrated in the private market while public comps stay bid on scarcity value; that would be a short-term positive for the current listed name, but only until the market starts discounting the new benchmark. The contrarian takeaway is that the headline valuation is less actionable than the signal it sends about capital intensity: the winner in space may be the firm that can fund iteration the cheapest, not the one with the cleanest pure-play story. That argues for being cautious on any long-only basket of small-cap space equities into the IPO window, because enthusiasm can mask dilution risk and a long path to free cash flow. In the near term, the most attractive setup is likely a relative-value expression rather than a directional bet on the sector. For the named AI/tech beneficiaries in the article, the relevance is mostly indirect: any capital markets reopening around frontier-tech IPOs can temporarily lift valuation multiples for adjacent innovation names, but that effect usually fades once investors refocus on cash burn and monetization quality. The real trade is whether the market begins to treat these assets as bundled “platform” stories, which would favor large-cap scale winners and penalize narrower, single-product companies.